Úplné zobrazení záznamu

Toto je statický export z katalogu ze dne 20.10.2018. Zobrazit aktuální podobu v katalogu.

Bibliografická citace

.
0 (hodnocen0 x )
(1) Půjčeno:1x 
BK
4th ed.
Oxford : Elsevier, c2013
xxi, 1013 s. : il. ; 29 cm

objednat
ISBN 978-0-08-097037-0 (váz.)
Obsahuje bibliografie a rejstřík
000244771
Contents // FORIWORD ix PREFACE xi // ACKNOWLEDGEMENTS xv // List of contri butors xvü about the Editors xxi // P A R T X // IMMUNOASSAY FUNDAMENTALS // 1.1 howto Use This Book ? // David Wild // 1.2 Immunoassay for beginners i // David Wild // 1.3 immunoassay Performance Measures h // Chris Davies // P A R I 2 // IMMUNOASSAY CONFIGURATIONS // 2.1 Principles of competitive and immunometric assays (Including ELISA) 29 // Chris Davies // 2.2 NON-COMPETITIVE IMMUNOASSAYS FOR SMALL MOLECULES—THE ANTI-COMPLEX AND SELECTIVE // Antibody Systems 6i // Colin H. Self, Stephen Thompson, Theresa Street, Kelly J. Lamb, Gordon Duffin, John L. Dessi, Maggie Turnbull // 2.3 HOMOGENEOUS IMMUNOASSAYS 67 // Edwin F. Ullman // 2.4 LATERAL FLOW IMMUNOASSAY SYSTEMS: EVOLUTION FROM THE CURRENT STATE OF THE ART TO THE NEXT GENERATION OF HIGHLY // Sensitive, Quantitative rapid Assays 89 // Brendan O’Farrell // 2.5 Ambient analyte assay 109 // Roger Ekins // 2.6 Free Analyte Immunoassay 123 // Nie D. Christofides // 2.7 Qualitative immunoassay—Features and // DESIGN 139 // Jianwen He, Simon Parker // 2.8 DETECTION OF ANTIBODIES RELEVANT TO // Infectious disease 149 // Steven Binder, Jennifer A. Isler // 2.9 Microsphere-Based multiplex immunoassays: Development and applications Using Luminex®xMAP® Technology 157 // Sherry A. Dunbar, Michaela R. Hoffmeyer // 2.10 lab-on-a-Chip, Micro- and Nanoscale immunoassay Systems, and microarrays 175 // Simon Rattle. Oliver Hofmann, Christopher P. Price, // Larry
J. Kricka, David Wild // 2.11 Immunological Biosensors 203 // Jason Reed, James K. Gimzewski // 2.12 Surface Plasmon Resonance in binding Site, kinetic, and Concentration Analyses 209 // Robert Karlsson // 2.13 MEASUREMENT OF SINGLE PROTEIN MOLECULES USING DIGITAL ELISA 223 // David M. Rissin, David H. Wilson, David C. Duffy // P A R T 3 // IMMUNOASSAY COMPONENTS // 3.1 ANTIBODIES 245 // Eryl Liddell // 3.2 Signal Generation and Detection systems (Excluding homogeneous assays) 267 // Ian Weeks, Larry J. Kricka, David Wild // 3.3 SEPARATION SYSTEMS 287 // David Wild, Wlad Kusnezow // 3.4 Conjugation Methods 301 // Alastair H. Dent // 3.5 Standardization and Calibration 315 // David Wild, Chris Sheehan // 3.6 Calibration Curve Fitting 323 // John Dunn, David Wild // P A R T 4 // Related Techniques // 4.1 the foundations of Immunochemistry 339 // Robert F. Ritchie // 4.2 IMMUNOHISTOCHEMISTRY AND IMMUNOCYTOCHEMISTRY 357 // Simon Renshaw // P A R T 5 // IMMUNOASSAY DEVELOPMENT // 5.1 Practical Guide to ELISA Development 38i // Jianwen He // v // vi // Contents // 5.2 METHOD EVALUATION—A PRACTICAL GUIDE 395 // Chris Sheehan, Jianwen He, Mari Smith // 5.3 INTERFERENCES IN IMMUNOASSAY 403 // Jason Y. Park, Larry J. Kricka // 5.4 IMMUNOASSAY DEVELOPMENT IN THE IN VITRO DIAGNOSTIC INDUSTRY 417 // Doug Brandt, Steve Figard // P A R T (j // IMMUNOASSAY IMPLEMENTATION // 6.1 Sample Collection, including participant Preparation and Sample handling 427 // Colin Wilde, Dorothée Out, Sara Johnson,
// Douglas A. Granger // 6.2 Quality Assurance 441 // Catharine M. Sturgeon // 6.3 poinT’OF’Care Testing 455 // James H. Nichols // 6.4 Choosing an Automated immunoassay System 465 // Lori J. Sokoli // Daniel W. Chan // 6.5 Immunoassay Troubleshooting Guide 469 // David Wild, Jianwen He // P A R T 7 // IMMUNOASSAY PRODUCT TECHNOLOGY // 7.1 INTRODUCTION TO IMMUNOASSAY PRODUCT TECHNOLOGY IN CLINICAL DIAGNOSTIC // Testing 509 // David Wild, Chris Sheehan, Steve Binder // 7.2 Market Trends 517 // David Ruckle // 7.3 Lateral Flow and Consumer // DIAGNOSTICS 533 // Sarah Tiplady // 7.4 CONSUMER DIAGNOSTICS—CLEARBLUE // Pregnancy and Fertility Testing 537 // Sarah Tiplady // 7.5 The Triage® System 541 // Thomas I. Koshy, Kenneth F. Buechler // 7.6 STRATUS® CS ACUTE CARE™ STÁT FLUOROMETRIC Analyzer 545 // Amy Sarli, W.N. McLellan // 7.7 I MX® 549 // Kent Ford // 7.8 AxSYM® 555 // Theresa Donahoe // 7.9 Abbott architect® family of Analyzers 561 // Frank A. Quinn, David A. Armbruster // 7.10 ADVIA Centaur® XP 567 // Jean Metzar // 7.11 IMMULITE® AND IMMULITE 1000 571 // Arthur L. Babson // 7.12 IMMULITE® 2000 AND IMMULITE 2000 XPI 575 // Arthur L. Babson // 7.13 VITROS® eciqjmmunodiagnostic System, V1TROS® 3600 IMMUNODLAGNOSTIC SYSTEM, AND VITROS® 5600 INTEGRATED SYSTEM 579 // John W. Backus. David Wild // 7.14 VITROS® IMMUNO-RATE AND MlCROTlP™ Assays 585 // John W. Backus, Susan J. Danielson, David A. Hilborn // 7.15 ACCESS 2 589 // Katherine M. Leith // 7.16 DXI 600
AND DXI 800 597 // Katherine M. Leith // 7.17 ELECSYS® IMMUNOASSAY SYSTEMS 603 // Mary Beth Myers // 7.18 PRISM™ 609 // Dinesh Shah, Jim Stewart // 7.19 P HAD LA LABORATORY SYSTEMS 617 // Angela Gore, Gareth Evans, Mats Rilven // P A R T 3 // IMMUNOASSAY APPLICATIONS OTHER THAN // Clinical Chemistry // 8.1 Immunoassay applications in Veterinary Diagnostics 623 // Thomas P. O’Connor, Jr., John Lawrence, Philip Andersen, Valerie Leathers, Erwin Workman // 8.2 LIGAND BINDING ASSAYS IN DRUG DEVELOPMENT 647 // Jeffrey M. Sailstad, Ronald R. Bowsher, Omar F. Laterza, William Nowatzke // P A R T 9 // immunoassay Clinical Applications (Human) // 9.1 Clinical Concepts 66i // Chris Davies // 9.2 THYROID 673 // Rhys John, Nie Christofides, Carole A. Spencer, David Wild // 9.3 The Adrenal Cortex 695 // Les Perry, Sami Medbak // 9.4 BONE AND CALCIUM METABOLISM 705 // William D. Fraser, Kay W. Colston, John C. Stevenson // 9.5 INFERTILITY 721 // Michael J. Wheeler // 9.6 In Vitro Fertilization and Embryo Transfer (IVF’ET) 735 // Richard Fleming, Sherry Faye // Contents // vii // 9.7 HIRSUTISM AND VIRILIZATION IN THE // Female 745 // Michael J. Wheeler // 9.8 PREGNANCY 757 // Kevin Spencer, Tim Chard // 9.9 Growth and growth hormone deficiency 777 // Gill Rumsby, Peter Hindmarsh, Michael Preece, Jane Pringle // 9.10 diabetes Mellitus 783 // Penny Clark, Tim McDonald // 9.11 Hematology 795 // Katy Evans, Zane Amenhotep, Derek Dawson, Harry Waters, John Ardern // 9.12 Cardiac Markers 817
Deborah French, Alan H.B. Wu // 9.13 Cancer Markers 833 // Hoon H. Sunwoo, Mavanur R. Suresh // 9.14 Allergy 857 Marcos Alcocer, Lars Yman // 9.15 Autoimmune Disease 869 // David F. Keren // 9.16 Gastrointestinal tract 89i // Arne Reseth, Richard Chapman, Radra Ramachandran, // Chris Sheehan // 9.17 Hepatitis 901 // Ravi Kaul // 9.18 HIV-1 AND HIV-2: CAUSATIVE AGENTS OF AIDS 913 // Catherine A. Brennan, Sushil G. Devare // 9.19 VIRAL DISEASES 919 // Carey-Ann D. Burnham, Christopher Doern, Steven R Binder // 9.20 BACTERIAL DISEASES 929 // Carey-Ann D. Burnham, Christopher Doern, Steven R. Binder // 9.21 PARASITES AND FUNGI 939 Steven R. Binder, Patrice D. Sarfati // 9.22 Therapeutic Drug monitoring (TDM) 945 // Philip A. Routledge, Alun D. Hutchings // 9.23 Drugs of abuse 963 // Alun D. Hutchings, Brian Widdop // INDEX 989 // Color version of figures in this book can be found at www.irnmunoassayhandbook.com

Zvolte formát: Standardní formát Katalogizační záznam Zkrácený záznam S textovými návěštími S kódy polí MARC